Okairos' Series B Round

Okairos raised a round of funding on September 21, 2010.

Okairos is a clinical-stage biopharmaceutical company, developing genetic vaccines for major infectious diseases - including malaria, hepatitis C, HIV, respiratory syncytial virus and cancer - using a…

Articles about Okairos' Series B Round: